Mitochondrial syndromes with leukoencephalopathies

Seminars in Neurology

Volumn 32, Issue 1, 2012, Pages 55-61

  Wong, Lee Jun C ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

DARS2; Leigh's disease; mitochondrial disorders; mitochondrial leukoencephalopathy; MNGIE; MPV17; POLG

Indexed keywords

ASPARTATE TRANSFER RNA LIGASE; METHIONINE; MITOCHONDRIAL DNA; PHENYLALANINE; THYMIDINE PHOSPHORYLASE;

ALPERS DISEASE; ARTICLE; BLOOD ANALYSIS; BRAIN ATROPHY; CEREBELLAR ATAXIA; CEREBRAL BLINDNESS; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; COMPLEX II DEFICIENCY; CYTOCHROME C OXIDASE DEFICIENCY; DISEASE SEVERITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GASTROINTESTINAL MOTILITY DISORDER; HEMIPARESIS; HUMAN; KEARNS SAYRE SYNDROME; LACTIC ACIDOSIS; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; LEUKOENCEPHALOPATHY; MELAS SYNDROME; MENTAL DETERIORATION; MERRF SYNDROME; MICROCEPHALY; MIGRAINE; MISSENSE MUTATION; MNGIE SYNDROME; MOLECULAR DIAGNOSIS; MOLECULAR INTERACTION; MUSCLE BIOPSY; MUSCLE WEAKNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONSET AGE; OXYGEN CONSUMPTION; PERCEPTION DEAFNESS; POINT MUTATION; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRIORITY JOURNAL; PTOSIS; PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY; RECURRENT DISEASE; RESPIRATORY CHAIN; TONIC CLONIC SEIZURE; WHITE MATTER;

DNA, MITOCHONDRIAL; DNA-DIRECTED DNA POLYMERASE; HUMANS; LEIGH DISEASE; LEUKOENCEPHALOPATHIES; MITOCHONDRIA; MITOCHONDRIAL DISEASES; MUTATION; SYNDROME;

EID: 84858139342     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0032-1306387     Document Type: Article

References (70)

1. Wallace DC, Lott MT, Brown MD, Kerstann K. Mitochondria and neuro-ophthalmologic diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D., eds. The Metabolic & Molecular Bases of Inherited Disease. Vol II. 8th ed. New York McGraw-Hill: 2001; 2425 2509
2. Koene S, Smeitink J. Mitochondrial medicine: entering the era of treatment. J Intern Med: 2009; 265 2 193 209
3. Pagliarini DJ, Calvo SE, Chang B., et al. A mitochondrial protein compendium elucidates complex I disease biology. Cell: 2008; 134 1 112 123 (Pubitemid 351916708)
4. Spinazzola A, Zeviani M. Disorders of nuclear-mitochondrial intergenomic signaling. Gene: 2005; 354 162 168 (Pubitemid 41116697)
5. Lebre AS, Rio M, Faivre d'Arcier L., et al. A common pattern of brain MRI imaging in mitochondrial diseases with complex I deficiency. J Med Genet: 2011; 48 1 16 23
6. Lerman-Sagie T, Leshinsky-Silver E, Watemberg N, Luckman Y, Lev D. White matter involvement in mitochondrial diseases. Mol Genet Metab: 2005; 84 2 127 136 (Pubitemid 40164572)
7. Moroni I, Bugiani M, Bizzi A, Castelli G, Lamantea E, Uziel G. Cerebral white matter involvement in children with mitochondrial encephalopathies. Neuropediatrics: 2002; 33 2 79 85 (Pubitemid 34654320)
8. Schaefer AM, Taylor RW, Turnbull DM, Chinnery PF. The epidemiology of mitochondrial disorderspast, present and future. Biochim Biophys Acta: 2004; 1659 2-3 115 120 (Pubitemid 39575497)
9. Elliott HR, Samuels DC, Eden JA, Relton CL, Chinnery PF. Pathogenic mitochondrial DNA mutations are common in the general population. Am J Hum Genet: 2008; 83 2 254 260
10. Wong LJ. Molecular genetics of mitochondrial disorders. Dev Disabil Res Rev: 2010; 16 2 154 162
11. de Lonlay-Debeney P, von Kleist-Retzow JC, Hertz-Pannier L., et al. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr: 2000; 136 2 209 214 (Pubitemid 30470992)
12. El-Hattab AW, Li FY, Schmitt E, Zhang S, Craigen WJ, Wong LJ. MPV17-associated hepatocerebral mitochondrial DNA depletion syndrome: new patients and novel mutations. Mol Genet Metab: 2010; 99 3 300 308
13. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science: 1999; 283 5402 689 692
14. Nishino I, Spinazzola A, Papadimitriou A., et al. Mitochondrial neurogastrointestinal encephalomyopathy: an autosomal recessive disorder due to thymidine phosphorylase mutations. Ann Neurol: 2000; 47 6 792 800 (Pubitemid 30390200)
15. Tang S, Wang J, Lee NC., et al. Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum. J Med Genet: 2011; 48 10 669 681
16. Scheper GC, van der Klok T, van Andel RJ., et al. Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet: 2007; 39 4 534 539 (Pubitemid 46514784)
17. Uluc K, Baskan O, Yildirim KA., et al. Leukoencephalopathy with brain stem and spinal cord involvement and high lactate: a genetically proven case with distinct MRI findings. J Neurol Sci: 2008; 273 1-2 118 122
18. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol: 1995; 16 2 233 239
19. Renard D, Bonnaure H, Labauge P. Teaching NeuroImages: diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes. Neurology: 2010; 75 3 e9
20. Ito S, Shirai W, Asahina M, Hattori T. Clinical and brain MR imaging features focusing on the brain stem and cerebellum in patients with myoclonic epilepsy with ragged-red fibers due to mitochondrial A8344G mutation. AJNR Am J Neuroradiol: 2008; 29 2 392 395 (Pubitemid 351287903)
21. Biancheri R, Rossi D, Cassandrini D, Rossi A, Bruno C, Santorelli FM. Cavitating leukoencephalopathy in a child carrying the mitochondrial A8344G mutation. AJNR Am J Neuroradiol: 2010; 31 9 E78 E79
22. Bhatti MT, Newman NJ. A multiple sclerosis-like illness in a man harboring the mtDNA 14484 mutation. J Neuroophthalmol: 1999; 19 1 28 33 (Pubitemid 30249281)
23. Jansen PH, van der Knaap MS, de Coo IF. Leber's hereditary optic neuropathy with the 11 778 mtDNA mutation and white matter disease resembling multiple sclerosis: clinical, MRI and MRS findings. J Neurol Sci: 1996; 135 2 176 180 (Pubitemid 26072592)
24. Lev D, Yanoov-Sharav M, Watemberg N, Leshinsky-Silver E, Lerman-Sagie T. White matter abnormalities in Leber's hereditary optic neuropathy due to the 3460 mitochondrial DNA mutation. Eur J Paediatr Neurol: 2002; 6 2 121 123 (Pubitemid 34436765)
25. Nikoskelainen EK, Marttila RJ, Huoponen K., et al. Leber's "pluso": neurological abnormalities in patients with Leber's hereditary optic neuropathy. J Neurol Neurosurg Psychiatry: 1995; 59 2 160 164
26. Fruhman G, Landsverk ML, Lotze TE., et al. Atypical presentation of Leigh syndrome associated with a Leber hereditary optic neuropathy primary mitochondrial DNA mutation. Mol Genet Metab: 2011; 103 2 153 160
27. Enns GM, Bai RK, Beck AE, Wong LJ. Molecular-clinical correlations in a family with variable tissue mitochondrial DNA T8993G mutant load. Mol Genet Metab: 2006; 88 4 364 371 (Pubitemid 44131508)
28. Hung PC, Wang HS. A previously undescribed leukodystrophy in Leigh syndrome associated with T9176C mutation of the mitochondrial ATPase 6 gene. Dev Med Child Neurol: 2007; 49 1 65 67
29. Brautbar A, Wang J, Abdenur JE., et al. The mitochondrial 13513G > A mutation is associated with Leigh disease phenotypes independent of complex I deficiency in muscle. Mol Genet Metab: 2008; 94 4 485 490
30. Gropman A, Chen TJ, Perng CL., et al. Variable clinical manifestation of homoplasmic G14459A mitochondrial DNA mutation. Am J Med Genet A: 2004; 124A 4 377 382 (Pubitemid 38141379)
31. Pereira C, Nogueira C, Barbot C., et al. Identification of a new mtDNA mutation (14724G > A) associated with mitochondrial leukoencephalopathy. Biochem Biophys Res Commun: 2007; 354 4 937 941 (Pubitemid 46216223)
32. Seigel RS, Seeger JF, Gabrielsen TO, Allen RJ. Computed tomography in oculocraniosomatic disease (Kearns-Sayre syndrome). Radiology: 1979; 130 1 159 164 (Pubitemid 9087350)
33. Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M. Neuropathology in Kearns-Sayre syndrome. Acta Neuropathol: 1990; 80 5 541 546 (Pubitemid 20316614)
34. Brown GK, Otero LJ, LeGris M, Brown RM. Pyruvate dehydrogenase deficiency. J Med Genet: 1994; 31 11 875 879 (Pubitemid 24336334)
35. Dahl HH, Brown GK. Pyruvate dehydrogenase deficiency in a male caused by a point mutation (F205L) in the E1 alpha subunit. Hum Mutat: 1994; 3 2 152 155 (Pubitemid 24077232)
36. Willemsen M, Rodenburg RJ, Teszas A, van den Heuvel L, Kosztolanyi G, Morava E. Females with PDHA1 gene mutations: a diagnostic challenge. Mitochondrion: 2006; 6 3 155 159 (Pubitemid 43890604)
37. Loeffen JL, Smeitink JA, Trijbels JM., et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat: 2000; 15 2 123 134 (Pubitemid 30078403)
38. Schuelke M, Smeitink J, Mariman E., et al. Mutant NDUFV1 subunit of mitochondrial complex I causes leukodystrophy and myoclonic epilepsy. Nat Genet: 1999; 21 3 260 261 (Pubitemid 29124929)
39. Loeffen J, Elpeleg O, Smeitink J., et al. Mutations in the complex I NDUFS2 gene of patients with cardiomyopathy and encephalomyopathy. Ann Neurol: 2001; 49 2 195 201 (Pubitemid 32157995)
40. Ogilvie I, Kennaway NG, Shoubridge EA. A molecular chaperone for mitochondrial complex I assembly is mutated in a progressive encephalopathy. J Clin Invest: 2005; 115 10 2784 2792 (Pubitemid 41434405)
41. Saada A, Edvardson S, Rapoport M., et al. C6ORF66 is an assembly factor of mitochondrial complex I. Am J Hum Genet: 2008; 82 1 32 38 (Pubitemid 351735948)
42. Ferreira M, Torraco A, Rizza T., et al. Progressive cavitating leukoencephalopathy associated with respiratory chain complex I deficiency and a novel mutation in NDUFS1. Neurogenetics: 2011; 12 1 9 17
43. Brockmann K, Bjornstad A, Dechent P., et al. Succinate in dystrophic white matter: a proton magnetic resonance spectroscopy finding characteristic for complex II deficiency. Ann Neurol: 2002; 52 1 38 46 (Pubitemid 34693741)
44. Burgeois M, Goutieres F, Chretien D, Rustin P, Munnich A, Aicardi J. Deficiency in complex II of the respiratory chain, presenting as a leukodystrophy in two sisters with Leigh syndrome. Brain Dev: 1992; 14 6 404 408 (Pubitemid 23057661)
45. Ghezzi D, Goffrini P, Uziel G., et al. SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy. Nat Genet: 2009; 41 6 654 656
46. Majoie CB, Akkerman EM, Blank C, Barth PG, Poll-The BT, den Heeten GJ. Mitochondrial encephalomyopathy: comparison of conventional MR imaging with diffusion-weighted and diffusion tensor imaging: case report. AJNR Am J Neuroradiol: 2002; 23 5 813 816 (Pubitemid 34525698)
47. Seijo-Martnez M, Castro del Ro M, Campos Y., et al. Unusual clinical findings and Complex III deficiency in a family with myotonic dystrophy. J Neurol Sci: 2003; 208 1-2 87 91 (Pubitemid 36294159)
48. Rahman S, Brown RM, Chong WK, Wilson CJ, Brown GKA. A SURF1 gene mutation presenting as isolated leukodystrophy. Ann Neurol: 2001; 49 6 797 800 (Pubitemid 32530248)
49. Timothy J, Geller T. SURF-1 gene mutation associated with leukoencephalopathy in a 2-year-old. J Child Neurol: 2009; 24 10 1296 1301
50. Shaibani A, Shchelochkov OA, Zhang S., et al. Mitochondrial neurogastrointestinal encephalopathy due to mutations in RRM2B. Arch Neurol: 2009; 66 8 1028 1032
51. Tang S, Dimberg EL, Milone M, Wong LJ. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations. J Neurol: 2011
52. Harding BN. Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): a personal review. J Child Neurol: 1990; 5 4 273 287 (Pubitemid 20319417)
53. Kollberg G, Moslemi AR, Darin N., et al. POLG1 mutations associated with progressive encephalopathy in childhood. J Neuropathol Exp Neurol: 2006; 65 8 758 768 (Pubitemid 44200316)
54. Brunetti-Pierri N, Selby K, O'Sullivan M., et al. Rapidly progressive neurological deterioration in a child with Alpers syndrome exhibiting a previously unremarkable brain MRI. Neuropediatrics: 2008; 39 3 179 183
55. Bao X, Wu Y, Wong LJ., et al. Alpers syndrome with prominent white matter changes. Brain Dev: 2008; 30 4 295 300 (Pubitemid 351335323)
56. Wong LJ, Naviaux RK, Brunetti-Pierri N., et al. Molecular and clinical genetics of mitochondrial diseases due to POLG mutations. Hum Mutat: 2008; 29 9 E150 E172
57. Milone M, Wang J, Liewluck T, Chen LC, Leavitt JA, Wong LJ. Novel POLG splice site mutation and optic atrophy. Arch Neurol: 2011; 68 6 806 811
58. Holve S, Hu D, Shub M, Tyson RW, Sokol RJ. Liver disease in Navajo neuropathy. J Pediatr: 1999; 135 4 482 493 (Pubitemid 30180478)
59. Karadimas CL, Vu TH, Holve SA., et al. Navajo neurohepatopathy is caused by a mutation in the MPV17 gene. Am J Hum Genet: 2006; 79 3 544 548 (Pubitemid 44384263)
60. Wong LJ, Brunetti-Pierri N, Zhang Q., et al. Mutations in the MPV17 gene are responsible for rapidly progressive liver failure in infancy. Hepatology: 2007; 46 4 1218 1227 (Pubitemid 350144786)
61. Spinazzola A, Viscomi C, Fernandez-Vizarra E., et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet: 2006; 38 5 570 575
62. Navarro-Sastre A, Martn-Hernndez E, Campos Y., et al. Lethal hepatopathy and leukodystrophy caused by a novel mutation in MPV17 gene: description of an alternative MPV17 spliced form. Mol Genet Metab: 2008; 94 2 234 239
63. Randolph LM, Jackson HA, Wang J., et al. Fatal infantile lactic acidosis and a novel homozygous mutation in the SUCLG1 gene: a mitochondrial DNA depletion disorder. Mol Genet Metab: 2011; 102 2 149 152
64. Isohanni P, Linnankivi T, Buzkova J., et al. DARS2 mutations in mitochondrial leucoencephalopathy and multiple sclerosis. J Med Genet: 2010; 47 1 66 70
65. Mierzewska H, van der Knaap MS, Scheper GC, Bekiesinska-Figatowska M, Szczepanik E, Jurkiewicz E. Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation in the first Polish patient. Brain Dev: 2011; 33 9 713 717
66. Tzoulis C, Tran GT, Gjerde IO., et al. Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J Neurol: 2011
67. Haas RH, Parikh S, Falk MJ., et al. Mitochondrial disease: a practical approach for primary care physicians. Pediatrics: 2007; 120 6 1326 1333 (Pubitemid 350223685)
68. Haas RH, Parikh S, Falk MJ., et al. Mitochondrial Medicine Society's Committee on Diagnosis. The in-depth evaluation of suspected mitochondrial disease. Mol Genet Metab: 2008; 94 1 16 37
69. Wong LJ, Scaglia F, Graham BH, Craigen WJ. Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab: 2010; 100 2 111 117
70. Vasta V, Ng SB, Turner EH, Shendure J, Hahn SH. Next generation sequence analysis for mitochondrial disorders. Genome Med: 2009; 1 10 100